Vous êtes ici

BetterLife Pharma Inc.

BetterLife Pharma  Inc.
Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
BETR
Indice CSE: 
Devise: 

BetterLife Pharma Inc. (“BetterLife”) is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Through its wholly owned subsidiary, Altum Pharmaceuticals Inc., BetterLife is refining and developing drug candidates from a broad set of complementary Interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.

Vous êtes ici

BetterLife Pharma Inc. (BETR)

SEDAR Information

Information d'entreprise

Addresse
300 - 1275 West 6th Avenue
Vancouver, BC V6H 1A6
Canada
Téléphone
604-805-7783
Fax
604-738-7134
Courriel
info@blifepharma.com
URL
http://www.abetterlifepharma.com
Date d’inscription à la cote
Mardi, décembre 19, 2017
Agent de transfert
National Securities Administrators Ltd.

Advertisement

Publicité

Capitalisation

Capitalisation: 
84,821,672
Réservé à l'émission: 
39,888,524

Bulletins

31/08/2020

2020-0836 – Changement Fondamental - BetterLife Pharma Inc. (BETR)

Le 31 aout/August 2020

Following a fundamental change review the common shares of BetterLife Pharma Inc. have requalified for listing.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News